The expression of Nrf2 in HCC tissue was suppressed by DPP4 inhibitor treatment [87], suggesting that Nrf2 downregulation resulted in the suppressed synthesis of purine nucleotides. The gene discussed is NFE2L2; the disease is hepatocellular carcinoma.